TrialBMC cancer2014

Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study.

Sasja F Mulder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.